Literature DB >> 1193320

A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.

I M Samloff, D M Secrist, E Passaro.   

Abstract

Serum group I pepsinogen (PG I) levels, basal acid output, and peak acid output (PAO) have been determined in 120 patients, 54 with duodenal ulcer, 14 with prepyloric ulcer, 12 with gastric ulcer, and 40 without ulcer. The correlation between serum PG I and PAO was statistically significant (r = 0.736, P less than 0.001) up to a serum PG I level of 250 ng per ml. Serum PG I levels above 250 ng per ml were associated with a plateau in the PAO. Each of 8 patients with a serum PG I of less than 40 ng per ml had a PAO of less than 10 mEq per hr. Of 34 patients with a serum PG I over 200 ng per ml, 29 (85.3%) had a PAO of greater than 40 mEq per hr and all had a PAO above 34 mEq per hr. Of 51 patients with a serum PG I between 60 and 150 ng per ml, 47 (92.2%) had a PAO of between 10 and 40 mEq per hr. The results indicate that a significant relationship exists between the concentration of PG I in serum and the acid secretory capacity of the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1193320

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.

Authors:  K Iijima; T Koike; N Ara; K Nakagawa; Y Kondo; K Uno; W Hatta; N Asano; A Imatani; T Shimosegawa
Journal:  J Gastroenterol       Date:  2014-06-22       Impact factor: 7.527

2.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

3.  Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.

Authors:  M Inoue
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Noninvasive assessment of gastric acid secretion in man. Application of electrical impedance tomography (EIT).

Authors:  S A Sarker; D Mahalanabis; P K Bardhan; N H Alam; K S Rabbani; A Kiber; M Hassan; S Islam; G J Fuchs; K Gyr
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

5.  Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.

Authors:  I Biemond; L F Crobach; J B Jansen; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells.

Authors:  Marju Gruno; Nadezhda Peet; Andres Tein; Riina Salupere; Meeli Sirotkina; Julio Valle; Ants Peetsalu; Enn K Seppet
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

7.  An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia.

Authors:  K Varis; I M Samloff; T Ihämaki; M Siurala
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

8.  Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.

Authors:  N Konishi; K Matsumoto; Y Hiasa; Y Kitahori; I Hayashi; H Matsuda
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

9.  The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

Authors:  Akiko Shiotani; Takashi Sakakibara; Yoshiyuki Yamanaka; Ryuji Nishi; Hiroshi Imamura; Minoru Fujita; Ken-ichi Tarumi; Tomoari Kamada; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-05-16       Impact factor: 7.527

10.  Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Authors:  Katsunori Iijima; Tomoyuki Koike; Yasuhiko Abe; Nobuyuki Ara; Kaname Uno; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-05-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.